Potassium Ion

Potassium Ion

SCHEMBL6564869

CCCCCCCCCCCCCCCCCC(=O)CNCCS(=O)(=O)[O-].[K+]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.46
HAO1 Q9UJM8 1/20 0.45
FAAH O00519 2/20 0.41
CES2 O00748 4/20 0.41
CES1 P23141 4/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
FABP3 P05413 5/20 0.39
PLA2G2A P14555 2/20 0.38
HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL6756334 1.00 EPHX2 (0.46) EPHX2HAO1FAAHCES2CES1
SCHEMBL2036114 0.97 EPHX2 (0.49) EPHX2HAO1FAAHCES2CES1
SCHEMBL9551953 0.97 EPHX2 (0.49) EPHX2HAO1FAAHCES2CES1
SCHEMBL9551951 0.97 EPHX2 (0.49) EPHX2HAO1FAAHCES2CES1
SCHEMBL9551957 0.95 EPHX2 (0.47) EPHX2HAO1FAAHCES2CES1
SCHEMBL143294 0.90 EPHX2 (0.60) EPHX2FAAHMAPTFABP3
SCHEMBL2043850 0.84 EPHX2 (0.48) EPHX2HAO1FAAHCES2CES1
SCHEMBL2047359 0.84 EPHX2 (0.48) EPHX2HAO1FAAHCES2CES1
SCHEMBL8376668 0.84 EPHX2 (0.48) EPHX2HAO1FAAHCES2CES1
SCHEMBL2042990 0.84 EPHX2 (0.48) EPHX2HAO1FAAHCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040091438-A1 Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation DOW CORNING TORAY SILICONE CO. LTD. (JP) 2004-05-13 US claimed
EP-1394215-A1 POLYORGANOSILOXANE EMULSION, PROCESS FOR PRODUCING THE SAME, AND MATERIAL FOR COSMETIC PREPARATION Dow Corning Toray Silicone Co., Ltd. (JP) 2004-03-03 EP claimed
US-20040091438-A1 Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation DOW CORNING TORAY SILICONE CO. LTD. (JP) 2004-05-13 US disclosed
EP-1394215-A1 POLYORGANOSILOXANE EMULSION, PROCESS FOR PRODUCING THE SAME, AND MATERIAL FOR COSMETIC PREPARATION Dow Corning Toray Silicone Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040091438-A1 Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation CUTA, UNG, PCNA EPHX2 1578/4885HAO1 398/4885FAAH 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.